| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0068 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |